Underinsurance  	Underinsurance  	 NNP	B-NP
and  	and  	 CC	O
adolescent  	adolescent  	 JJ	O
immunization  	immunization  	 JJ	B-NP
delivery  	delivery  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
The  	The  	 DT	O
goal  	goal  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
association  	association  	 NN	O
of  	of  	 IN	O
being  	being  	 VBG	O
underinsured  	underinsured  	 NNS	O
and  	and  	 CC	O
receiving  	receiving  	 VBG	B-NP
doses  	doses  	 NNS	I-NP
at  	at  	 IN	O
a  	a  	 DT	O
health  	health  	 NN	B-NP
department  	department  	 NN	I-NP
clinic  	clinic  	 NN	I-NP
( 	( 	 -LRB-	O
HDC 	HDC 	 NNP	B-NP
)  	)  	 -RRB-	O
with  	with  	 IN	O
not  	not  	 RB	O
receiving  	receiving  	 VBG	O
all  	all  	 DT	O
recommended  	recommended  	 JJ	O
adolescent  	adolescent  	 JJ	O
vaccine  	vaccine  	 NN	B-NP
doses 	doses 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
5657  	5657  	 CD	O
adolescents 	adolescents 	 NNS	O
,  	,  	 ,	O
13  	13  	 CD	O
to  	to  	 TO	O
17  	17  	 CD	O
years  	years  	 NNS	O
of  	of  	 IN	O
age 	age 	 NN	O
,  	,  	 ,	O
were  	were  	 VBD	O
sampled  	sampled  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
National  	National  	 NNP	B-NP
Immunization  	Immunization  	 NNP	I-NP
Survey-Teen  	Survey-Teen  	 NNP	I-NP
in  	in  	 IN	O
2006-2007 	2006-2007 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
63.9 	63.9 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
adolescents  	adolescents  	 NN	O
were  	were  	 VBD	O
covered  	covered  	 VBN	O
by  	by  	 IN	O
private  	private  	 JJ	O
health  	health  	 NN	B-NP
insurance 	insurance 	 NN	I-NP
.  	.  	 .	O
Among  	Among  	 IN	O
privately  	privately  	 RB	O
insured  	insured  	 JJ	O
adolescents 	adolescents 	 NNS	O
,  	,  	 ,	O
approximately  	approximately  	 RB	O
31.3 	31.3 	 CD	O
%  	%  	 NN	O
were  	were  	 VBD	O
underinsured 	underinsured 	 VBN	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
with  	with  	 IN	O
fully  	fully  	 RB	O
insured  	insured  	 JJ	O
adolescents 	adolescents 	 NNS	O
,  	,  	 ,	O
underinsured  	underinsured  	 JJ	B-NP
adolescents  	adolescents  	 NNS	I-NP
were  	were  	 VBD	O
more  	more  	 RBR	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
receive  	receive  	 VB	O
doses  	doses  	 NNS	O
at  	at  	 IN	O
an  	an  	 DT	O
HDC  	HDC  	 NNP	B-NP
for  	for  	 IN	I-NP
tetanus-diphtheria  	tetanus-diphtheria  	 FW	I-NP
toxoids 	toxoids 	 FW	I-NP
/ 	/ 	 FW	I-NP
tetanus  	tetanus  	 FW	I-NP
toxoids-reduced  	toxoids-reduced  	 FW	O
diphtheria  	diphtheria  	 FW	B-NP
toxoids-acellular  	toxoids-acellular  	 FW	I-NP
pertussis  	pertussis  	 FW	I-NP
vaccine  	vaccine  	 FW	I-NP
( 	( 	 -LRB-	O
25.1 	25.1 	 NNP	O
%  	%  	 NN	O
vs  	vs  	 VBD	O
6.2 	6.2 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.05 	.05 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
tetravalent  	tetravalent  	 FW	B-NP
meningococcal  	meningococcal  	 FW	I-NP
conjugate  	conjugate  	 FW	O
vaccine  	vaccine  	 FW	O
( 	( 	 -LRB-	O
11.5 	11.5 	 CD	O
%  	%  	 NN	O
vs  	vs  	 VBD	O
2.5 	2.5 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.05 	.05 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
quadrivalent  	quadrivalent  	 JJ	B-NP
human  	human  	 JJ	I-NP
papillomavirus  	papillomavirus  	 JJ	I-NP
vaccine  	vaccine  	 NN	I-NP
( 	( 	 -LRB-	O
16.2 	16.2 	 CD	O
%  	%  	 NN	O
vs  	vs  	 VBD	O
3.4 	3.4 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.05 	.05 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Also 	Also 	 RB	O
,  	,  	 ,	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
fully  	fully  	 RB	O
insured  	insured  	 JJ	O
adolescents 	adolescents 	 NNS	O
,  	,  	 ,	O
underinsured  	underinsured  	 JJ	B-NP
adolescents  	adolescents  	 NNS	I-NP
who  	who  	 WP	O
received  	received  	 VBD	O
doses  	doses  	 VBN	O
at  	at  	 IN	O
an  	an  	 DT	O
HDC  	HDC  	 NNP	B-NP
had  	had  	 VBD	O
lower  	lower  	 RBR	O
estimated  	estimated  	 JJ	O
rates  	rates  	 NNS	O
of  	of  	 IN	O
vaccination  	vaccination  	 JJ	B-NP
coverage  	coverage  	 NN	I-NP
for  	for  	 IN	I-NP
tetanus-diphtheria  	tetanus-diphtheria  	 FW	I-NP
toxoids 	toxoids 	 FW	I-NP
/ 	/ 	 FW	I-NP
tetanus  	tetanus  	 FW	I-NP
toxoids-reduced  	toxoids-reduced  	 FW	O
diphtheria  	diphtheria  	 FW	B-NP
toxoids-acellular  	toxoids-acellular  	 FW	I-NP
pertussis  	pertussis  	 FW	I-NP
vaccine  	vaccine  	 FW	I-NP
( 	( 	 -LRB-	O
58.5 	58.5 	 NNP	O
%  	%  	 NN	O
vs  	vs  	 VBD	O
70.9 	70.9 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.05 	.05 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
tetravalent  	tetravalent  	 FW	B-NP
meningococcal  	meningococcal  	 FW	I-NP
conjugate  	conjugate  	 FW	O
vaccine  	vaccine  	 FW	O
( 	( 	 -LRB-	O
10.8 	10.8 	 CD	O
%  	%  	 NN	O
vs  	vs  	 VBD	O
25.8 	25.8 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.05 	.05 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
quadrivalent  	quadrivalent  	 JJ	B-NP
human  	human  	 JJ	I-NP
papillomavirus  	papillomavirus  	 JJ	I-NP
vaccine  	vaccine  	 NN	I-NP
( 	( 	 -LRB-	O
7.8 	7.8 	 CD	O
%  	%  	 NN	O
vs  	vs  	 VBD	O
14.3 	14.3 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.05 	.05 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Underinsured  	Underinsured  	 JJ	B-NP
adolescents  	adolescents  	 NNS	I-NP
who  	who  	 WP	O
receive  	receive  	 VBP	O
doses  	doses  	 VBN	O
at  	at  	 IN	O
an  	an  	 DT	O
HDC  	HDC  	 NNP	B-NP
have  	have  	 VBP	O
lower  	lower  	 JJR	O
rates  	rates  	 NNS	O
of  	of  	 IN	O
vaccination  	vaccination  	 JJ	B-NP
coverage  	coverage  	 NN	I-NP
than  	than  	 IN	O
do  	do  	 VBP	O
fully  	fully  	 RB	O
insured  	insured  	 JJ	O
adolescents 	adolescents 	 NNS	O
.  	.  	 .	O
